{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:19:50Z","timestamp":1771064390107,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.02.058","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T12:46:22Z","timestamp":1456922782000},"page":"1965-1970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Universal varicella vaccine immunization in Japan"],"prefix":"10.1016","volume":"34","author":[{"given":"Tetsushi","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7892","key":"10.1016\/j.vaccine.2016.02.058_bib0310","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"issue":"7978","key":"10.1016\/j.vaccine.2016.02.058_bib0315","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(76)92397-7","article-title":"Use of live varicella vaccine in children with acute leukaemia or other malignancies","volume":"2","author":"Hattori","year":"1976","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.058_bib0320","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.60.6.805","article-title":"Application of a live varicella vaccine in children with acute leukemia or other malignant diseases","volume":"60","author":"Izawa","year":"1977","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.058_bib0325","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.65.2.346","article-title":"Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy","volume":"65","author":"Ha","year":"1980","journal-title":"Pediatrics"},{"issue":"7966","key":"10.1016\/j.vaccine.2016.02.058_bib0330","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(76)92746-X","article-title":"Letter: contact infection from live varicella vaccine recipients","volume":"1","author":"Asano","year":"1976","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0335","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/infdis\/152.5.863","article-title":"Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients","volume":"152","author":"Asano","year":"1985","journal-title":"J Infect Dis"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2016.02.058_bib0340","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0345","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0350","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.02.058_bib0355","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.058_bib0360","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.058_bib0365","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10156-013-0577-x","article-title":"Varicella vaccination in Japan: necessity of implementing a routine vaccination program","volume":"19","author":"Ozaki","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2016.02.058_bib0370","unstructured":"Simultaneous administration of varicella vaccine and other recommended childhood vaccines United States, 1995\u20131999. MMWR Morb Mortal Wkly Rep 2001;50(47):1058\u201361."},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.058_bib0375","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/173.3.731","article-title":"Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children","volume":"173","author":"Watson","year":"1996","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.058_bib0380","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3476(89)80598-0","article-title":"Placebo-controlled trial of varicella vaccine given with or after measles\u2013mumps\u2013rubella vaccine","volume":"114","author":"Englund","year":"1989","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0390","first-page":"29","article-title":"Nationwide survey for severe varicella and zoster in iatrogenic immunocompromised patients","volume":"23","author":"Nakai","year":"2011","journal-title":"J Pediatr Infect Dis Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.058_bib0395","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.058_bib0400","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","article-title":"The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination","volume":"28","author":"Civen","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0405","doi-asserted-by":"crossref","first-page":"e1389","DOI":"10.1542\/peds.2012-3303","article-title":"Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study","volume":"131","author":"Baxter","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.058_bib0410","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.1542\/peds.2013-4037","article-title":"Epidemiology of pediatric herpes zoster after varicella infection: a population-based study","volume":"135","author":"Wen","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0415","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"J Am Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.02.058_bib0420","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2016.02.058_bib0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0264-410X(99)00261-3","article-title":"The cost-effectiveness of varicella vaccine programs for Australia","volume":"18","author":"Scuffham","year":"1999","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2016.02.058_bib0430","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0264-410X(98)00394-6","article-title":"A cost benefit analysis of routine varicella vaccination in Spain","volume":"17","author":"Diez Domingo","year":"1999","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2016.02.058_bib0435","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.058_bib0440","doi-asserted-by":"crossref","first-page":"212","DOI":"10.11150\/kansenshogakuzasshi1970.80.212","article-title":"[Cost-effectiveness analysis of routine immunization for varicella in Japan]","volume":"80","author":"Sugawara","year":"2006","journal-title":"Kansenshogaku Zasshi"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.058_bib0445","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study","volume":"292","author":"Seward","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0450","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2016.02.058_bib0455","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1542\/peds.2011-0017","article-title":"Varicella in infants after implementation of the US varicella vaccination program","volume":"128","author":"Chaves","year":"2011","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.058_bib0460","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2016.02.058_bib0465","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2016.02.058_bib0470","first-page":"S61","article-title":"Clinical experience with Oka live varicella vaccine in Japan","volume":"61","author":"Takahashi","year":"1985","journal-title":"Postgrad Med J"},{"issue":"4 Pt 2","key":"10.1016\/j.vaccine.2016.02.058_bib0475","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1542\/peds.78.4.757","article-title":"Live attenuated varicella vaccine use in immunocompromised children and adults","volume":"78","author":"Gershon","year":"1986","journal-title":"Pediatrics"},{"issue":"22","key":"10.1016\/j.vaccine.2016.02.058_bib0480","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella vaccine collaborative study group","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.058_bib0485","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJM198803033180904","article-title":"The risk of zoster after varicella vaccination in children with leukemia","volume":"318","author":"Lawrence","year":"1988","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0490","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.99.1.35","article-title":"Varicella and zoster in children after kidney transplantation: long-term results of vaccination","volume":"99","author":"Broyer","year":"1997","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0495","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.healun.2007.09.028","article-title":"Incidence and clinical characteristics of herpes zoster after lung transplantation","volume":"27","author":"Manuel","year":"2008","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.vaccine.2016.02.058_bib0500","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe\u2014taking the practical approach","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.vaccine.2016.02.058_bib0505","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1097\/INF.0b013e31828b7def","article-title":"Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses","volume":"32","author":"Bonanni","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.02.058_bib0510","first-page":"1416","article-title":"Efficacy and safety of co-administration of live attenuated varicella vaccine and measles\u2013rubella (MR) vaccine","volume":"117","author":"Ohashi","year":"2013","journal-title":"J Japan Pediatr Soc"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2016.02.058_bib0515","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.058_bib0520","doi-asserted-by":"crossref","unstructured":"van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine Feb 1;30(6):1225\u201334.","DOI":"10.1016\/j.vaccine.2011.11.026"},{"issue":"13","key":"10.1016\/j.vaccine.2016.02.058_bib0525","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2016.02.058_bib0530","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2016.02.058_bib0535","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.02.058_bib0540","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/522162","article-title":"The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.02.058_bib0545","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1086\/522131","article-title":"Risk of herpes zoster in adults immunized with varicella vaccine","volume":"197","author":"Hambleton","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.02.058_bib0550","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0b013e31819c1041","article-title":"An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients\u2014Arkansas, 2006","volume":"28","author":"Gould","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.02.058_bib0555","unstructured":"Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Record 2014;89(25):265\u201387."},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.058_bib0560","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/INF.0000000000000444","article-title":"Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students","volume":"33","author":"Thomas","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0565","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4161\/hv.23451","article-title":"Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain","volume":"9","author":"Cenoz","year":"2013","journal-title":"Hum Vaccines Immunother"},{"issue":"9925","key":"10.1016\/j.vaccine.2016.02.058_bib0570","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles\u2013mumps\u2013rubella\u2013varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","author":"Prymula","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0575","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1542\/peds.2013-0863","article-title":"Impact of a routine two-dose varicella vaccination program on varicella epidemiology","volume":"132","author":"Bialek","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2016.02.058_bib0580","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2016.02.058_bib0585","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/JCM.00216-08","article-title":"Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification","volume":"46","author":"Higashimoto","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.02.058_bib0590","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2016.02.058_bib0595","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/infdis\/jiu137","article-title":"Focal encephalitis following varicella-zoster virus reactivation without rash in a healthy immunized young adult","volume":"210","author":"Halling","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.058_bib0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/INF.0b013e318273e43d","article-title":"Fatal wild-type varicella-zoster virus encephalitis without a rash in a vaccinated child","volume":"32","author":"Ibraheem","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.02.058_bib0605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/653113","article-title":"Evaluation of laboratory methods for diagnosis of varicella","volume":"51","author":"Leung","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.058_bib0610","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jviromet.2013.06.031","article-title":"Cycling probe technology to quantify and discriminate between wild-type varicella-zoster virus and Oka vaccine strains","volume":"193","author":"Ihira","year":"2013","journal-title":"J Virol Methods"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T03:09:17Z","timestamp":1654484957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1600253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":61,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X1600253X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Universal varicella vaccine immunization in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}